TURKISH JOURNAL OF PEDIATRICS, vol.62, no.4, pp.541-550, 2020 (SCI-Expanded)
Background and objectives. Quantification of serum Epstein-Barr virus (EBV) DNA and/or cell-free total DNA (cf-DNA) may become valuable sources for prognosis evaluation and monitoring treatment response in lymphomas. We aimed to investigate their roles as potential markers in pediatric Hodgkin (HL) and non-Hodgkin lymphomas (NHL).